References:
1. Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(Suppl. 1):8-16.
2. Silverberg JI, Gelfand JM. Pediatric atopic dermatitis: an overview. Am J Clin Dermatol. 2015;16(3):209-223.
3. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008;86(5):408-416.
4. Sadikov, N. et al. (2021) ‘The Effectiveness of Using Prednisolone in Children with Community – Acquired Pneumonia’, Asian Journal of Pediatric Research, 5(3), pp. 1–8. doi: 10.9734/ajpr/2021/v5i330173.
5. Hanifin JM, Reed ML; Eczema Prevalence and Severity in Children Study. A population-based survey of eczema prevalence in the United States. Dermatitis. 2007;18(2):82-91.
6. Gough H, Grabenhenrich L, Reich A, Eckers N, Neneman A, Nockher WA, et al. The impact of atopic dermatitis on health-related quality of life in children: a multicenter cohort study. Pediatr Allergy Immunol. 2016;27(2):161-167.
7. Sadikov N.I., Aliyev A.L., Kuziyev D.V., Akhrorkhonov R.A. 2023. Immunological status in acute pneumonia in children under 2 years old with atopic dermatitis: A parallel group clinical trial. Eur. J. Pediat. Dermatol. 33 (2):77-80. 10.26326/2281-9649.33.2.2477.
8. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;Suppl 92:44-47.
9. Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med. 1996;24(5):743-752.